X

Xenon Pharmaceuticals
D

XENE

38.360
USD
-0.23
(-0.60%)
Market Open
Volume
1,457
EPS
-3
Div Yield
-
P/E
-14
Market Cap
2,924,551,133
OverviewSignalsIdeasNews
Related Instruments
    ALNY
    ALNY
    -6.265
    (-2.55%)
    239.240 USD
    BIIB
    BIIB
    1.670
    (1.14%)
    148.260 USD
    B
    BLUE
    -0.74000
    (-8.72%)
    7.75000 USD
    GILD
    GILD
    0.100
    (0.11%)
    92.670 USD
    N
    NBIX
    -0.720
    (-0.53%)
    134.740 USD
    R
    RARE
    -1.050
    (-2.38%)
    43.140 USD
    S
    SGEN
    0
    (0%)
    0.000000 USD
    S
    SRPT
    -0.070
    (-0.06%)
    118.900 USD
    VRTX
    VRTX
    2.98
    (0.75%)
    400.13 USD
    X
    XNCR
    0.160
    (0.66%)
    24.320 USD
    More
News

Title: Xenon Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company committed to developing therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system, or CNS, conditions. The product candidates of the group include XEN1101, XEN901, and XEN496 for Epilepsy, and Nav1.7 oral inhibitors for Pain. Geographically the activities are carried out throughout Canada.